William C. Roell

2.2k total citations · 3 hit papers
20 papers, 1.3k citations indexed

About

William C. Roell is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, William C. Roell has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in William C. Roell's work include Diabetes Treatment and Management (11 papers), Pharmacology and Obesity Treatment (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). William C. Roell is often cited by papers focused on Diabetes Treatment and Management (11 papers), Pharmacology and Obesity Treatment (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). William C. Roell collaborates with scholars based in United States, Denmark and Finland. William C. Roell's co-authors include Axel Haupt, Ruth E. Gimeno, Tamer Coşkun, Shweta Urva, Charles Benson, Julie S. Moyers, Daniel A. Briere, Corina Loghin, Kyle W. Sloop and Krister Bokvist and has published in prestigious journals such as Cell Metabolism, Diabetes and The FASEB Journal.

In The Last Decade

William C. Roell

19 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

2018 603 citations Tamer Coşkun, Kyle W. Sloop et al. Molecular Metabolism profile →
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept

2022 180 citations Tamer Coşkun, Shweta Urva et al. Cell Metabolism profile →
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation

2025 18 citations Éric Ravussin, Guillermo Sánchez‐Delgado et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William C. Roell United States	11	883	496	341	328	282	20	1.3k
Meena Asmar Denmark	22	1.2k 1.3×	595 1.2×	660 1.9×	256 0.8×	297 1.1×	32	1.7k
Cendrine Cabou France	17	373 0.4×	343 0.7×	301 0.9×	52 0.2×	160 0.6×	28	978
Michishige Terasaki Japan	15	738 0.8×	345 0.7×	415 1.2×	152 0.5×	96 0.3×	45	1.1k
Teruo Jojima Japan	18	756 0.9×	355 0.7×	412 1.2×	66 0.2×	167 0.6×	47	1.3k
Renée Komorowski United States	16	430 0.5×	544 1.1×	302 0.9×	113 0.3×	336 1.2×	24	1.2k
Alicia Deng United States	15	195 0.2×	395 0.8×	882 2.6×	787 2.4×	227 0.8×	23	2.0k
Pharis Mohideen United States	14	692 0.8×	550 1.1×	289 0.8×	67 0.2×	152 0.5×	25	1.4k
Jun Agata Japan	19	197 0.2×	455 0.9×	127 0.4×	121 0.4×	230 0.8×	26	1.3k
Sidath Katugampola United Kingdom	11	113 0.1×	197 0.4×	259 0.8×	286 0.9×	187 0.7×	17	791
Akira Matsutani Japan	18	210 0.2×	428 0.9×	452 1.3×	116 0.4×	116 0.4×	37	840

Countries citing papers authored by William C. Roell

Since Specialization

Citations

This map shows the geographic impact of William C. Roell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Roell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Roell more than expected).

Fields of papers citing papers by William C. Roell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Roell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Roell. The network helps show where William C. Roell may publish in the future.

Co-authorship network of co-authors of William C. Roell

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Roell. A scholar is included among the top collaborators of William C. Roell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Roell. William C. Roell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wen, Yi, Yanzhu Lin, Yan Chen, et al.. (2025). Decreases in circulating ANGPTL3 /8 concentrations following retatrutide treatment parallel reductions in serum lipids. Diabetes Obesity and Metabolism. 27(10). 5985–5995. 1 indexed citations

Ravussin, Éric, Guillermo Sánchez‐Delgado, Corby K. Martin, et al.. (2025). Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. Cell Metabolism. 37(5). 1060–1074.e4. 18 indexed citations breakdown →

Roell, William C., Tamer Coşkun, Teayoun Kim, et al.. (2024). Characterization of LY3324954 a long-acting glucagon-receptor agonist. Molecular Metabolism. 91. 102073–102073. 2 indexed citations

Pratt, Edward, Filip K. Knop, Shweta Urva, et al.. (2024). A Long-Acting Glucose Dependent Insulinotropic Polypeptide Receptor Agonist Shows Weight Loss Without Nausea or Vomiting. Diabetologie und Stoffwechsel. 19(S 01). S77–S77.

Knop, Filip K., Shweta Urva, Mallikarjuna Rettiganti, et al.. (2024). A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves gastrointestinal tolerability of glucagon-like peptide 1 receptor agonist therapy. Diabetologie und Stoffwechsel. 19(S 01). S73–S73. 3 indexed citations

Knop, Filip K., et al.. (2023). 56-OR: A Long-Acting Glucose-Dependent Insulinotropic Polypeptide Receptor Agonist Shows Weight Loss without Nausea or Vomiting. Diabetes. 72(Supplement_1). 17 indexed citations

Coşkun, Tamer, Shweta Urva, William C. Roell, et al.. (2022). LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metabolism. 34(9). 1234–1247.e9. 180 indexed citations breakdown →

Chen, Yanyun, Adam R. Mezo, Tamer Coşkun, et al.. (2021). 682-P: Novel Dual Glucagon and Glucagon-Like Peptide-1 Receptor Agonist LY3305677 Improves Glucose Control, Reduces Body Weight, and Increases Energy Expenditure in Mice. Diabetes. 70(Supplement_1). 10 indexed citations

Coşkun, Tamer, Julie S. Moyers, William C. Roell, et al.. (2021). 679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes. Diabetes. 70(Supplement_1). 9 indexed citations

10.

Wilson, Jonathan M., Amir Nikooienejad, Deborah A. Robins, et al.. (2020). The dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 22(12). 2451–2459. 113 indexed citations

11.

Chen, Yan, Robert W. Siegel, Mariam Ehsani, et al.. (2020). Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4. Biochemical and Biophysical Research Communications. 534. 498–503. 10 indexed citations

12.

Chen, Yan, Robert W. Siegel, Mariam Ehsani, et al.. (2020). Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids. Journal of Lipid Research. 61(8). 1203–1220. 108 indexed citations

13.

Baker, Hana E., Alexander Kiel, Ajit Regmi, et al.. (2019). Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization. Basic Research in Cardiology. 114(3). 25–25. 58 indexed citations

14.

Samms, Ricardo J., Michael E. Christe, Xiaoping Ruan, et al.. (2019). 1009-P: The Dual GIP and GLP-1 Receptor Agonist Tirzepatide Regulates Lipid and Carbohydrate Metabolism through GIPR in Adipose Tissue. Diabetes. 68(Supplement_1). 4 indexed citations

15.

Coşkun, Tamer, Kyle W. Sloop, Corina Loghin, et al.. (2018). LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Molecular Metabolism. 18. 3–14. 603 indexed citations breakdown →

16.

Peng, Sheng-Bin, Robert D. Van Horn, Tinggui Yin, et al.. (2017). Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587. Oncotarget. 8(55). 94619–94634. 22 indexed citations

17.

Dage, Jeffrey L., Antoine Fouillet, William C. Roell, et al.. (2014). Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons. Psychopharmacology. 231(6). 1105–1124. 43 indexed citations

18.

Payne, Gregory A., Léna Borbouse, Ian N. Bratz, et al.. (2008). Endogenous Adipose‐Derived Factors Diminish Coronary Endothelial Function via Inhibition of Nitric Oxide Synthase. Microcirculation. 15(5). 417–426. 42 indexed citations

19.

Gangaraju, Rajashekhar, William C. Roell, Dmitry O. Traktuev, et al.. (2008). Adipogenesis of Adipose Stromal Cells is Reduced by Endothelial Cell Co‐cultivation: Role for Wnt‐signaling. The FASEB Journal. 22(S1). 2 indexed citations

20.

Gangaraju, Rajashekhar, Dmitry O. Traktuev, William C. Roell, et al.. (2008). IFATS Collection: Adipose Stromal Cell Differentiation Is Reduced by Endothelial Cell Contact and Paracrine Communication: Role of Canonical Wnt Signaling. Stem Cells. 26(10). 2674–2681. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact